PharmaEngine (4162) — Cash Flow Quality Index

Latest as of September 2025: 0.39x

PharmaEngine (4162) has a Cash Flow Quality Index of 0.39x as of September 2025. Operating cash flow of NT$53.01 Million is below net income of NT$136.46 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of PharmaEngine to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.39x
Operating CF / Net Income

Operating Cash Flow

NT$53.01 Million
TWD

Net Income

NT$136.46 Million
TWD

Data as of

Sep 2025
Most recent filing

PharmaEngine Cash Flow Quality Index (2011–2024)

Historical Cash Flow Quality Index for PharmaEngine across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 4162 operating cash flow.

Annual Cash Flow Quality Index for PharmaEngine (2011–2024)

Year-by-year earnings quality comparison for PharmaEngine.

Year Quality Index Operating CF (TWD) Net Income YoY Change
2024 0.26x NT$456.73 Million NT$1.75 Billion ▼ -72.1%
2023 0.94x NT$256.97 Million NT$274.65 Million ▲ +81.8%
2022 0.51x NT$202.01 Million NT$392.46 Million ▼ -69.8%
2021 1.70x NT$929.67 Million NT$545.39 Million ▲ +1880.4%
2020 0.09x NT$64.77 Million NT$752.48 Million ▼ -73.4%
2019 0.32x NT$16.08 Million NT$49.67 Million ▼ -92.9%
2018 4.55x NT$745.23 Million NT$163.77 Million ▲ +766.5%
2017 -0.68x NT$-339.30 Million NT$496.99 Million ▼ -165.7%
2016 1.04x NT$870.38 Million NT$837.91 Million ▼ -5.6%
2015 1.10x NT$447.99 Million NT$406.99 Million ▲ +4.4%
2014 1.05x NT$131.09 Million NT$124.32 Million ▼ -24.8%
2012 1.40x NT$68.64 Million NT$48.99 Million ▲ +45.3%
2011 0.96x NT$275.49 Million NT$285.71 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.